Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
iNOS is a homodimeric enzyme that catalyzes the production of nitric oxide (NO) from L-arginine. It is induced by inflammatory cytokines and microbial products and plays a key role in immune defense and inflammation. Overexpression of iNOS is implicated in various diseases, making it a therapeutic target for modulating inflammatory responses and oxidative stress.
Inhibition of iNOS activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase inducible isoform (iNOS).